Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

Seroprevalence of Hepatitis B virus and Hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan

Authors: Mustafa Abdalla Ali Abou, Yassir Mohammed Eltahir, Abdelwahid Saeed Ali

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and the possible risk factors among blood donors in Nyala, South Dar Fur State of western Sudan, which has never been studied before. A total of 400 male blood donors were tested for the detection of HBsAg and anti-HCV antibodies, (6.25%) were found reactive for HBsAg and (0.65%) were reactive for anti-HCV antibodies. The highest seroprevalence (30.8%) was found in those between 19-24 and 37-42 years for HBsAg, whereas it was (50%) in those between 31-36 years for anti-HCV antibodies. Unprotected sexual activities (20%) was the most apparent predisposing risk factor for both HBV and HCV seroreactors, followed by razor sharing (13.3%), parenteral drug injections (10%), history of migration to Egypt and alcoholism (6.6%) for each, tattooing and surgical procedures (3.3%) for each and (36.6%) were not aware for their condition. Serum alanine aminotansferase (ALT) was elevated in (30.7%) of HBV seroreactors and in (50%) of HCV seroreactors. Serum albumin was reduced in (23.1%) HBV and in (50%) HCV seroreactors. The study concluded that the seroprevalence of HBV and HCV was in an intermediate and low rates respectively and unprotected sexual activities was the major risk factor for infection in the population studied.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH: Pathogenesis, natural history, treatment and prevention of hepatitis C. Annals of Internal Medicine 2000, 132: 296-305.CrossRefPubMed Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH: Pathogenesis, natural history, treatment and prevention of hepatitis C. Annals of Internal Medicine 2000, 132: 296-305.CrossRefPubMed
2.
3.
go back to reference Omer RE, Veer Van't P, Kadaru AM, Kampman E, El Khidir IM, Fedail SS, Kok FJ: The role of hepatitis B and hepatitis C viral infections in incidence of hepatocellular carcinoma in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001, 95: 487-491. 10.1016/S0035-9203(01)90013-6CrossRefPubMed Omer RE, Veer Van't P, Kadaru AM, Kampman E, El Khidir IM, Fedail SS, Kok FJ: The role of hepatitis B and hepatitis C viral infections in incidence of hepatocellular carcinoma in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001, 95: 487-491. 10.1016/S0035-9203(01)90013-6CrossRefPubMed
4.
go back to reference Brooks FG, Butel FJ, Morse AS: Hepatitis viruses. In Medical Microbiology. 22nd edition. Appleton and Lang, New York; 2001:403. Brooks FG, Butel FJ, Morse AS: Hepatitis viruses. In Medical Microbiology. 22nd edition. Appleton and Lang, New York; 2001:403.
5.
go back to reference Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA: Hepatitis viruses. In Medical Microbiology. 4th edition. Mosby, St. Louis; 2002:591. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA: Hepatitis viruses. In Medical Microbiology. 4th edition. Mosby, St. Louis; 2002:591.
6.
go back to reference Bahatia R, Ichhpujani RI: Viral hepatitis. In Essentials of Medical Microbiology. 3rd edition. Jaypee Brothers, Medical Publishers, Ltd, New delhi; 2004:396-406. Bahatia R, Ichhpujani RI: Viral hepatitis. In Essentials of Medical Microbiology. 3rd edition. Jaypee Brothers, Medical Publishers, Ltd, New delhi; 2004:396-406.
7.
go back to reference World Health Organization: Hepatitis B Surface Antigen Assays: Operational Characteristics. (Phase 1), (Report 2) 2004, 2. World Health Organization: Hepatitis B Surface Antigen Assays: Operational Characteristics. (Phase 1), (Report 2) 2004, 2.
8.
go back to reference Nagi AM, Altyeb HA, Ahmed AM: Seroprevalence of Hepatitis B and C Viral Infections among blood donors in Shendi, River Nile State, Sudan. Research Journal of Medicine and Medical Sciences 2007,2(2):122-126. Nagi AM, Altyeb HA, Ahmed AM: Seroprevalence of Hepatitis B and C Viral Infections among blood donors in Shendi, River Nile State, Sudan. Research Journal of Medicine and Medical Sciences 2007,2(2):122-126.
9.
go back to reference Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I: Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virology Journal 2007, 4: 104. 10.1186/1743-422X-4-104PubMedCentralCrossRefPubMed Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I: Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virology Journal 2007, 4: 104. 10.1186/1743-422X-4-104PubMedCentralCrossRefPubMed
10.
go back to reference McCarthy MC, El-Tigani A, Khalid IO, Hyams KC: Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Transactions of Royal Society of Tropical Medicine and Hygiene 1994, 88: 534-536. 10.1016/0035-9203(94)90150-3CrossRef McCarthy MC, El-Tigani A, Khalid IO, Hyams KC: Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Transactions of Royal Society of Tropical Medicine and Hygiene 1994, 88: 534-536. 10.1016/0035-9203(94)90150-3CrossRef
11.
go back to reference Mudawi HMY, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, Saeed OK, Fedail SS: Epidemiology of HCV Infection in Gezira State of Central Sudan. Journal of Medical Virology 2007, 79: 383-385. 10.1002/jmv.20780CrossRefPubMed Mudawi HMY, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, Saeed OK, Fedail SS: Epidemiology of HCV Infection in Gezira State of Central Sudan. Journal of Medical Virology 2007, 79: 383-385. 10.1002/jmv.20780CrossRefPubMed
12.
go back to reference Scott J, McMahon B, Bruden D, Sullivan D, Homan C, Christensen C, Gretch D: High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clinical Infectious Diseases 2006,42(7):945-952. 10.1086/500938CrossRefPubMed Scott J, McMahon B, Bruden D, Sullivan D, Homan C, Christensen C, Gretch D: High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clinical Infectious Diseases 2006,42(7):945-952. 10.1086/500938CrossRefPubMed
13.
go back to reference Smith AF, Beckett GJ, Walker SW, Rae PWH: Clinical Biochemistry. Six edition. 1998, 113. Smith AF, Beckett GJ, Walker SW, Rae PWH: Clinical Biochemistry. Six edition. 1998, 113.
14.
go back to reference Baron DN: A short Textbook of chemical Pathology. In ELBS edition of fourth edition. Richard Clay Ltd, Bungay, Suffolk; 1982:196. Baron DN: A short Textbook of chemical Pathology. In ELBS edition of fourth edition. Richard Clay Ltd, Bungay, Suffolk; 1982:196.
15.
go back to reference Peng XM, Huang GM, Li JG, Mei YY, Gao ZL: High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World Journal of Gastroenterology 2005,11(20):3131-3134.PubMedCentralCrossRefPubMed Peng XM, Huang GM, Li JG, Mei YY, Gao ZL: High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World Journal of Gastroenterology 2005,11(20):3131-3134.PubMedCentralCrossRefPubMed
16.
go back to reference Al-Arabi MA, Hyams KC, Mahgoub M, Al-Haj AA, El-Ghorab N: Non-A, Non-B Hepatitis in Omdurman, Sudan. Journal of Medical Virology 1987, 21: 217-222. 10.1002/jmv.1890210304CrossRefPubMed Al-Arabi MA, Hyams KC, Mahgoub M, Al-Haj AA, El-Ghorab N: Non-A, Non-B Hepatitis in Omdurman, Sudan. Journal of Medical Virology 1987, 21: 217-222. 10.1002/jmv.1890210304CrossRefPubMed
17.
go back to reference Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M, Watts S, Fix AD, Strickland GT, Anwar W, Sallam I: Hepatitis C in a community in Upper Egypt: I. cross-sectional survey. American Journal of Tropical Medicine and Hygiene 2000, 63: 236-241.PubMed Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M, Watts S, Fix AD, Strickland GT, Anwar W, Sallam I: Hepatitis C in a community in Upper Egypt: I. cross-sectional survey. American Journal of Tropical Medicine and Hygiene 2000, 63: 236-241.PubMed
Metadata
Title
Seroprevalence of Hepatitis B virus and Hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan
Authors
Mustafa Abdalla Ali Abou
Yassir Mohammed Eltahir
Abdelwahid Saeed Ali
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-146

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine